STRUCTURAL BIOLOGY-INFORMED OPTIMIZATION OF ANTIBODY-DRUG CONJUGATES FOR OVARIAN CANCER WITH AN EMPHASIS ON MINIMIZING TOXICITY
$408,816FY2025Defense Health AgencyDOD
The General Hospital Corporation
Investigators
View source on USAspending →STRUCTURAL BIOLOGY-INFORMED OPTIMIZATION OF ANTIBODY-DRUG CONJUGATES FOR OVARIAN CANCER WITH AN EMPHASIS ON MINIMIZING TOXICITY · GrantIndex